A large, multicenter clinical trial comparing different resuscitation strategies, as well as the use of an impedence threshold device, has stopped enrollment, based on findings that all strategies were equally effective.

Human embryonic stem cells could be used to help restore cognitive abilities in patients after radiation for brain tumors, according to study appearing online Nov. 9 in the Proceedings of the National Academy of Sciences.

An Agency for Healthcare Research and Quality (AHRQ) report, examining the cost of end-of-life care and hospitalization for individuals and payors within and outside of the Medicare system in 2007, found that the average cost of 765,651 hospital patient stays ending in death totaled $26,035 per patient.

Almost a quarter of heart failure patients with Medicare are back in the hospital within a month after discharge, researchers reported in the Nov. 11 issue of Circulation: Heart Failure.

AtriCure, a developer of cardiac surgical ablation systems, has reached a tentative settlement agreement with the Department of Justice (DoJ) in a qui tam case filed in 2007 for $3.8 million plus interest over a five-year period.

Post-lumpectomy radiation treatment for early-stage breast cancer can be safely reduced to four weeks by delivering a higher daily dose, according to the five-year results of a phase II study presented Wednesday at the 2009 American Society for Radiation Oncology (ASTRO) in Chicago.

Radiation therapy and chemotherapy given before prostatectomy is safe and may have the potential to reduce cancer recurrence and improve patient survival, based on study findings presented this week at the 2009 American Society of Radiology Oncology (ASTRO) conference in Chicago.

Whole-brain radiation therapy and stereotactic radiosurgery, when used together in the treatment of brain tumors, present a greater risk of significant decline in learning and memory function by four months, according to a randomized trial published in the November edition of Lancet Oncology.